Neointima formation after vascular injury: is it all about CD39?
Subramanian
P
P
Schober
A
A
D000818:Animals; D015703:Antigens, CD / Q000627:therapeutic use*; D001081:Apyrase / Q000627:therapeutic use*; D001808:Blood Vessels / Q000293:injuries*; D005343:Fibrinolytic Agents; D006801:Humans; D017539:Tunica Intima / Q000187:drug effects* / Q000254:growth & development; D014652:Vascular Diseases / Q000188:drug therapy
D015703:Antigens, CD; D005343:Fibrinolytic Agents; D001081:Apyrase; C067869:CD39 antigen